You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Colorcon
AstraZeneca
Baxter
Boehringer Ingelheim

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

CEFOXITIN SODIUM - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for cefoxitin sodium and what is the scope of freedom to operate?

Cefoxitin sodium is the generic ingredient in seven branded drugs marketed by Acs Dobfar, Acs Dobfar Spa, Fresenius Kabi Usa, Hikma Farmaceutica, Hospira Inc, West-ward Pharms Int, B Braun, Mylan Institutional, Merck, and Samson Medcl, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for cefoxitin sodium. Six suppliers are listed for this compound.

Recent Clinical Trials for CEFOXITIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Haining Health-Coming Biotech Co., Ltd.Phase 2

See all CEFOXITIN SODIUM clinical trials

Pharmacology for CEFOXITIN SODIUM
Medical Subject Heading (MeSH) Categories for CEFOXITIN SODIUM

US Patents and Regulatory Information for CEFOXITIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065239-001 Mar 2, 2010 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira Inc CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065312-001 Feb 13, 2006 DISCN No No   Start Trial   Start Trial   Start Trial
Hikma Farmaceutica CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065238-001 Mar 12, 2010 AP RX No No   Start Trial   Start Trial   Start Trial
Acs Dobfar Spa CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065464-001 Aug 31, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
Acs Dobfar CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065414-001 Jun 12, 2009 AP RX No Yes   Start Trial   Start Trial   Start Trial
Mylan Institutional MEFOXIN IN PLASTIC CONTAINER cefoxitin sodium INJECTABLE;INJECTION 063182-001 Jan 25, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Institutional MEFOXIN cefoxitin sodium INJECTABLE;INJECTION 050517-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Johnson and Johnson
Moodys
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.